Roche Keeps Shopping: Mirus Acquisition Bolsters RNAi Portfolio

 
• By Brooke McManus

Firm will pay $125 million for access to Wisconsin-based Mirus’ Dynamic PolyConjugates technology.

More from Archive

More from Pink Sheet